#1 Clinical Trials Search in Europe

Tianeptine

This article examines the use of tianeptine, a unique antidepressant medication, in various clinical trials. Tianeptine has shown promise in treating conditions such as major depressive disorder, bipolar disorder, post-mastectomy pain syndrome, and cognitive impairments associated with COVID-19. The trials explore tianeptine’s efficacy compared to other antidepressants and its potential to improve cognitive function and alleviate pain symptoms.

Table of Contents

What is Tianeptine?

Tianeptine is a unique antidepressant and anxiolytic (anti-anxiety) medication that has been used clinically in Europe, Asia, and South America since the late 1980s[1]. It is known by various brand names, including Stablon (Servier) and Tianeurax[2][1]. Unlike many other antidepressants available in the United States, tianeptine has a different mechanism of action, primarily affecting the brain’s opioid system[1].

Medical Conditions Treated with Tianeptine

Tianeptine is used to treat several mental health and neurological conditions, including:

  • Major Depressive Disorder (MDD): Tianeptine is primarily used as an antidepressant for treating MDD, especially in cases where other antidepressants have not been effective[1][3].
  • Bipolar Depression: Some studies are investigating the use of tianeptine as an adjunctive (add-on) therapy for bipolar depression[2].
  • Anxiety Disorders: Tianeptine has anxiolytic properties, making it potentially useful for treating anxiety[2].
  • Post-Mastectomy Pain Syndrome (PMPS): Research is being conducted on tianeptine’s effectiveness in treating chronic pain after breast cancer surgery[4].
  • COVID-19 Related Cognitive Impairment (“Covid Fog”): Ongoing studies are exploring tianeptine’s potential in treating cognitive symptoms experienced by some COVID-19 survivors[5].

How Tianeptine Works

Tianeptine’s mechanism of action is unique compared to other antidepressants. Here’s what we know about how it works:

  • Opioid System Interaction: Tianeptine acts as a selective agonist of the mu-opioid receptor (MOR), which is similar to how the body’s natural pain-relieving chemicals (endorphins) work[1].
  • Neurotransmitter Modulation: It affects various neurotransmitters in the brain, including serotonin, dopamine, and glutamate[2].
  • Neuroprotection: Tianeptine may have neuroprotective effects, potentially helping to prevent cellular damage in the brain[2].
  • Stress Response Reduction: It can reduce the body’s stress response, which may help with stress-related behavioral issues[2].

Dosage and Administration

The dosage of tianeptine can vary depending on the condition being treated and the patient’s age. Here are some general guidelines based on the clinical trials:

  • For depression and anxiety: 12.5 mg taken three times daily[2][6].
  • For older patients (over 70 years): 12.5 mg taken twice daily[5].
  • For post-mastectomy pain: 12.5 mg taken three times daily[4].

It’s important to note that tianeptine should only be taken under the supervision of a healthcare professional, as dosages may need to be adjusted based on individual response and side effects.

Potential Side Effects

While tianeptine is generally well-tolerated, it can cause side effects. Some potential side effects include:

  • Nausea and vomiting
  • Constipation
  • Dizziness
  • Drowsiness or sedation
  • Headache
  • Dry mouth

As with any medication, it’s important to discuss potential side effects with your healthcare provider[3].

Ongoing Research

Tianeptine is currently being studied for various conditions and potential applications:

  • Treatment-Resistant Depression: Research is ongoing to determine if tianeptine can be effective for patients who haven’t responded to other antidepressants[1].
  • Cognitive Function in Autism Spectrum Disorder (ASD): Studies are investigating how tianeptine affects brain function in individuals with ASD[7].
  • Post-COVID Cognitive Impairment: Researchers are exploring tianeptine’s potential in treating cognitive symptoms experienced by some COVID-19 survivors, often referred to as “Covid fog”[5].
  • Chronic Pain Management: Tianeptine’s unique mechanism of action is being studied for its potential in managing chronic pain conditions[4].

As research continues, our understanding of tianeptine’s potential benefits and risks may evolve. It’s important for patients to stay informed and consult with their healthcare providers about the latest developments in tianeptine research and its potential applications for their specific conditions.

Aspect Details
Main Conditions Studied Major Depressive Disorder, Bipolar Disorder, Post-Mastectomy Pain Syndrome, Treatment-Resistant Depression, COVID-19 related cognitive impairments
Mechanism of Action Selective agonist of mu-opioid receptor, stimulates serotonin uptake, affects glutamate system
Potential Benefits Improved mood, cognitive function enhancement, pain relief, neuroprotection
Comparison Treatments Escitalopram, Pregabalin, Placebo
Unique Applications Post-mastectomy pain management, COVID-19 related cognitive impairment treatment
Study Designs Randomized controlled trials, double-blind studies, comparative effectiveness research
Outcome Measures Depression scales, cognitive function tests, pain assessments, quality of life measures

FAQ

  • What is tianeptine and how does it work? Tianeptine is an atypical antidepressant that acts as a selective agonist of the mu-opioid receptor. It stimulates the uptake of serotonin and has neuroprotective properties. Unlike traditional antidepressants, tianeptine affects the glutamate system and may improve cognitive function.
  • What conditions are being studied with tianeptine in clinical trials? Clinical trials are investigating tianeptine for various conditions, including major depressive disorder, bipolar depression, post-mastectomy pain syndrome, treatment-resistant depression, and cognitive impairments associated with COVID-19 (known as 'covid fog').
  • How does tianeptine compare to other antidepressants in clinical trials? Some trials are comparing tianeptine to other antidepressants like escitalopram and pregabalin. These studies aim to assess tianeptine's efficacy in improving mood symptoms, cognitive function, and quality of life compared to established treatments.
  • What are the potential benefits of tianeptine for cognitive function? Tianeptine has shown promise in improving cognitive function, particularly in patients with major depressive disorder and those experiencing 'covid fog' after COVID-19 infection. It may help with memory, attention, and executive functions.
  • Are there any unique applications of tianeptine being studied? Yes, tianeptine is being studied for its potential in treating post-mastectomy pain syndrome in breast cancer patients and for alleviating cognitive impairments associated with COVID-19. These applications explore tianeptine's analgesic and neuroprotective properties.

Ongoing Clinical Trials on Tianeptine

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

Glossary

  • Tianeptine: An atypical antidepressant that acts as a selective agonist of the mu-opioid receptor, stimulating serotonin uptake and possessing neuroprotective properties.
  • Major Depressive Disorder (MDD): A mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities, often requiring treatment with antidepressants.
  • Bipolar Disorder: A mental health condition characterized by alternating periods of depression and mania or hypomania, requiring careful management of mood symptoms.
  • Post-Mastectomy Pain Syndrome (PMPS): Chronic pain that persists for more than three months after breast cancer surgery, affecting the chest, armpit, or arm area.
  • Treatment-Resistant Depression (TRD): A form of depression that does not respond adequately to two or more antidepressant treatments.
  • Covid Fog: Cognitive impairments experienced by some individuals after COVID-19 infection, including difficulties with memory, attention, and executive functions.
  • Mu-Opioid Receptor (MOR): A type of opioid receptor in the brain that tianeptine targets, which is involved in pain regulation and mood.
  • Serotonin: A neurotransmitter that plays a crucial role in regulating mood, anxiety, and happiness.
  • Glutamate System: A neurotransmitter system in the brain involved in learning, memory, and synaptic plasticity, which tianeptine may influence.
  • Neuroprotective: Having the ability to protect nerve cells from damage or degeneration.
  • Cognitive Function: Mental processes involved in gaining knowledge and comprehension, including thinking, knowing, remembering, judging, and problem-solving.
  • Escitalopram: A selective serotonin reuptake inhibitor (SSRI) antidepressant used as a comparison treatment in some tianeptine trials.
  • Pregabalin: An anticonvulsant and anxiolytic medication used to treat nerve pain and anxiety, compared to tianeptine in some studies.
  • Pharmacological Magnetic Resonance Imaging (phMRI): A neuroimaging technique used to study the effects of drugs on brain function and activity.

References

  1. https://clinicaltrials.gov/study/NCT04249596
  2. https://clinicaltrials.gov/study/NCT00879372
  3. https://clinicaltrials.gov/study/NCT04446039
  4. https://clinicaltrials.gov/study/NCT05935059
  5. https://clinicaltrials.gov/study/NCT06012552
  6. https://clinicaltrials.gov/study/NCT01309776
  7. https://clinicaltrials.gov/study/NCT04145076